QUICK FACTS

Engineering
T-cells for patients
in need

CellPoint enables clinicians to treat cancer by retargeting patient immune cells at the point-of-care.

READ MORE ABOUT US

SHORT VEIN TO VEIN

Treat when needed with a turnaround time of 1 week

available & affordable

Efficient and fully scalable: unlimited slots

LOCAL MANUFACTURING

Closed and automated processing without complex logistics

REAL TIME MONITORING

Secure online platform for real-time control
OUR VISION

disrupt
time-to-treatment
and costs

Affordable and widely available

CellPoint has been founded to provide affordable and readily available CAR-T treatments for all patients in need. We focus on quality and patient safety, while driving down the time-to-treatment and costs by automation at the point-of-care.
Proud to present our

collaborations & partners

CLINICAL CENTERS OF EXCELLENCE

Cellpoint
Point of Care
locations

Hospitals have been selected across EU and US based on excellent clinical teams and facilities to deliver CAR-T treatments

Central supplies, quality assurance, and support by CellPoint staff

Become a partner